Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Biochemical and Biophysical Research Communications|May 2, 2015
Osteocalcin protects pancreatic beta cell function and survival under high glucose conditionsKaren Kover, Yun Yan, Pei Ying Tong, et al.
Diabetes Care|March 3, 2018
Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic FactorsMaria Jose Redondo, Ingrid Libman, Peiyao Cheng, et al.
Australian and New Zealand Journal of Public Health|December 14, 2011
Validity of self-reported height and weight and derived body mass index in middle-aged and elderly individuals in AustraliaSuan Peng Ng, Rosemary Korda, Mark Clements, et al.
International Journal of Cancer|December 17, 2011
Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: a case-control studyVisalini Nair-Shalliker, David P Smith, Sam Egger, et al.
Tissue Engineering|May 6, 2006
Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beadsJulia F Markusen, Christopher Mason, Dearbhla A Hull, et al.
The Journal of Clinical Endocrinology and Metabolism|July 26, 2022
Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 DiabetesLaura M Jacobsen, Brian N Bundy, Heba M Ismail, et al.
Environmental Health Perspectives|January 13, 2010
Are current or future mesothelioma epidemics in Hong Kong the tragic legacy of uncontrolled use of asbestos in the past?Lap Ah Tse, Ignatius Tak-sun Yu, William Goggins, et al.
The New England Journal of Medicine|October 29, 2015
Excess Mortality among Persons with Type 2 DiabetesMauro Tancredi, Annika Rosengren, Ann-Marie Svensson, et al.
The Lancet. Oncology|August 15, 2021
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trialTobias Nordström, Andrea Discacciati, Martin Bergman, et al.
European Urology Oncology|May 24, 2024
Effectiveness and Cost-effectiveness of Artificial Intelligence-assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation StudyXiaoyang Du, Shuang Hao, Henrik Olsson, et al.
Pageof 16